Patent US2957056A successfully refreshed from Google Patents.
Patent US4990457A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4990457A Expired / Lapsed US ⏱️ 0.0 years remaining

Whole blood dry analysis element

Assignee: Fujifilm Holdings Corp
•
Filing: 1989-04-04
•
Granted: 1991-02-05
•
Expires: 2009-04-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A dry analysis element for determination of a particular constituent in erythrocyte-containing blood, which comprises at least a water permeable porous spreading layer and a water permeable reagent layer arranged on the side opposite to the liquid accepting face of the porous spreading layer, and which contains a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least either of the water permeable layers. The porous spreading layer contains cholic acid, deoxycholic acid or salts thereof to enable accurate determination of the constituents in whole blood, irrespective of the hematocrit value.

Inventors

  • 👤 Mitsutoshi Tanaka
  • 👤 Takaki Arai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 20:55
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/52; G01N33/525; Y; Y10; Y10S; Y10S435/00; Y10S435/805

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 124 words
A dry analysis element for the determination of a component in erythrocyte-containing blood which comprises at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face for the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 2
Dependent Claim 124 words
A dry analysis element for the determination of a component in erythrocyte-containing blood which comprises at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face for the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 3
Dependent Claim 19 words
The analysis element of claim 1 wherein said porous spreading layer contains an alkali metal salt of deoxycholic acid.
Claim 4
Dependent Claim 35 words
The analysis element of claim 1 wherein the compound is selected from the group consisting of cholic acid, lithocholic acid, taurocholic acid, glycocholic acid, deoxycholic acid, chenodeoxycholic acid, taurodeoxycholic acid, glycodeoxy-cholic acid, and their salts.
Claim 5
Dependent Claim 14 words
The analysis element of claim 3 wherein the salt is an alkali metal salt.
Claim 6
Dependent Claim 21 words
The analysis element of claim 4 wherein the alkali metal salt is selected from the group consisting of sodium and potassium.
Claim 7
Dependent Claim 21 words
The analysis element of claim 1 wherein the amount of said compound is from about 0.5 to 6 g/m 2 .
Claim 8
Dependent Claim 21 words
The analysis element of claim 6 wherein the amount of said compound is from about 1 to 4 g/m 2 .
Claim 9
Dependent Claim 155 words
In a method for the analysis of a component in an erythrocyte-containing blood sample wherein a droplet size sample of the blood is introduced to a dry analysis element and the quantity of the component is determined by optical analysis, the improvement which comprises said element having at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face of the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water-permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 10
Dependent Claim 155 words
In a method for the analysis of a component in an erythrocyte-containing blood sample wherein a droplet size sample of the blood is introduced to a dry analysis element and the quantity of the component is determined by optical analysis, the improvement which comprises said element having at least two water permeable layers which include a reagent layer and a porous spreading layer having a liquid-accepting face, the reagent layer being arranged on the side opposite to the liquid-accepting face of the porous spreading layer, and containing a reagent composition capable of producing an optically detectable substance in the presence of an analyte in at least one of the water-permeable layers, said porous spreading layer containing a compound selected from the group consisting of cholic acids, deoxycholic acids, and salts thereof, said compound being present in an amount effective to substantially prevent analysis errors due to variation in the hematocrit value of a blood sample.
Claim 11
Dependent Claim 12 words
The method of claim 8 wherein non-hydrophobic constituents in blood are determined.
Claim 12
Dependent Claim 11 words
The method of claim 8 wherein saccharides in blood are determined.
Claim 13
Dependent Claim 11 words
The method of claim 8 wherein glucose in blood is determined.
Claim 14
Dependent Claim 18 words
The method of claim 8 wherein said porous spreading layer contains an alkali metal salt of deoxycholic acid.
Claim 15
Dependent Claim 34 words
The method of claim 8 wherein the compound is selected from the group consisting of cholic acid, lithocholic acid, taurocholic acid, glycocholic acid, deoxycholic acid, chenodeoxycholic acid, taurodeoxycholic acid, glycodeoxycholic acid, and their salts.
Claim 16
Dependent Claim 13 words
The method of claim 8 wherein the salt is an alkali metal salt.
Claim 17
Dependent Claim 20 words
The method of claim 8 wherein the alkali metal salt is selected from the group consisting of sodium and potassium.
Claim 18
Dependent Claim 20 words
The method of claim 8 wherein the amount of said compound is from about 0.5 to 6 g/m 2 .
Claim 19
Dependent Claim 20 words
The method of claim 8 wherein the amount of said compound is from about 1 to 4 g/m 2 .
Claim 20
Dependent Claim 23 words
The method of claim 8 wherein the blood to be analyzed has a hematocrit value in the range from about 25 to 70%.

References Cited (Backward Citations)

US4777139A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-02-04 1994-08-06 1995-02-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-02-04 1998-08-06 1999-02-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-02-04 2002-08-06 2003-02-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag